Rafael Fonseca recently shared a post on X:
“Long term CASSIOPEIA shows what was expected – longer use of daratumumab results in better outcomes. 2×2 design (love these) allows this conclusion.”
Source: Rafael Fonseca/X
Dr. Rafael Fonseca, MD, is a hematologist at Mayo Clinic, specializing in multiple myeloma and related conditions.. Dr. Fonseca’s expertise extends to diagnosing and treating plasma cell disorders, leading clinical trials that have advanced myeloma treatment.
